Characterizing lung resident mesenchymal stem cells in idiopathic pulmonary fibrosis patients
A Martin(Health Research Institute of the Balearic Islands), Ernest Sala(Hospital Universitario Son Espases), Andreas Jahn(University of Washington), Cristina Villena(Hospital Universitario Son Espases), Orlando Gigirey(Hospital Universitario Son Espases), Ángel Francisco Carvajal(Hospital Universitario Son Espases), María Molina‐Molina(Instituto de Salud Carlos III), Carlos Bocos(Health Research Institute of the Balearic Islands), J. Velasco(Hospital Universitario Son Espases), Janet M. Oliver(Health Research Institute of the Balearic Islands), Jaime Pons(Health Research Institute of the Balearic Islands), Cristina Gómez(Hospital Universitario Son Espases), Ana Montes(Guy's and St Thomas' NHS Foundation Trust), Catalina Crespı́(Health Research Institute of the Balearic Islands)
Cited by 1
Related Papers
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
|The Lancet Oncology|2021|614
WNT1-inducible signaling protein–1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis
|Journal of Clinical Investigation|2009|556
Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis
|American Journal of Respiratory and Critical Care Medicine|2019|343